FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ONGERICIMAB
异名/同义词IMMUNOGLOBULIN G4, ANTI-(NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL JS002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS002 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HUMANIZED MONOCLONAL ANTIBODY
JS 002
JS002
JS-002
ONGERICIMAB
ONGERICIMAB [INN]
ONGERICIMAB [WHO-DD]
CAS登记号2145096-91-7
物质唯一标识(Unique Ingredient Identifier)X126G5DZ36
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System